38 results
ARS
2024 FY
ABSI
Absci Corporation
23 Apr 24
Annual report to shareholders
4:10pm
.......................................................................................................................... 78 Item 4. Mine Safety Disclosures … better safety profiles in patients. Hence, building large training data sets for biologic drugs interactions offers the potential for AI models
8-K
EX-1.1
ABSI
Absci Corporation
28 Feb 24
Absci Announces Proposed Public Offering of Common Stock
4:06pm
to pollution or the protection of human health or safety, the environment, natural resources, hazardous or toxic substances or wastes, pollutants … , distribution, storage, marketing, advertising, promotion, sale, export, import, use, handling, safety, efficacy, or manufacturing of pharmaceutical
424B5
v4e un848ya5q8
28 Feb 24
Prospectus supplement for primary offering
8:34am
8-K
jtw7a2ae0 1mvch
27 Feb 24
Results of Operations and Financial Condition
4:45pm
424B5
ota s0vh2d0rb
27 Feb 24
Prospectus supplement for primary offering
4:40pm
8-K
EX-1.1
lfcms15l v487
16 Jun 23
Entry into a Material Definitive Agreement
4:23pm
ARS
dgy86kk
28 Apr 23
Annual report to shareholders
12:00am
8-K
EX-3.1
qvv16di cufr0pwjlm
16 Dec 22
Amendments to Articles of Incorporation or Bylaws
4:07pm
DEF 14A
2ckqhk63lpt
26 Apr 22
Definitive proxy
4:39pm
10-K
nturx5rx6fy6kyxrre
22 Mar 22
Annual report
5:20pm